February 17, 2016 Comments Off on MindMaze’s valuation at $1.1 billion – February 17, 2016
MindMaze, one of the top 10 healthcare companies in Switzerland, has raised $100 million in funding so it can continue to create VR devices for stroke patients. The company is now valued at $1.1 billion. A spinoff from the Swiss Federal Institute of Technology, MindMaze is considered as the world’s first multisensory computing platform. Its breakthrough technology combines virtual reality, augmented reality, neuroscience and motion capture to create a medical-grade “neural virtual reality platform.” It has a VR/AR headset called MindLeap that can train a stroke patient’s brain to regain motor function. MindLeap technology is now being used for stroke victim therapy in European hospitals.
You can read more about MindMaze here.
© 2017 Online Agility Investments, Acquisitions and Venture Capital Database | Internet DealBook. All Rights Reserved.